Each year, the TU/e Sensing Team (T.E.S.T.) invents and develops a biosensor for the SensUs competition.
The goal is to improve diagnostics in healthcare by using novel research and putting it into practice to create a state-of-the-art biosensor.
With biosensors, diseases can be detected in their early stages and be prevented.
In September 2023, our team competes with a sensor to detect Glial fibrillary acidic protein (GFAP), which is a marker for detecting Traumatic Brain Injury (TBI).
TBI is a disease that has approximately 64-74 million new cases each year. TBI patients suffer from memory loss, cognitive dysfunction or behavioural disturbance. It is important that the severity of TBI can be diagnosed rapidly, so that patients can receive the appropriate treatment. Proper treatment can improve patients’ life and, therefore, we are eager to contribute to the development of a biosensor for TBI.